Article

Enhanced Anticancer Activity of Nanoformulation of Dasatinib against Triple-Negative Breast Cancer by Reduced Metabolic Degradation

2021-04-27

Abstract excerpt

Triple negative breast cancer (TNBC) is the most aggressive breast cancer accounting for around 15% of identified breast cancer cases. TNBC, by lacking estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), is unresponsive to current targeted therapies. Existing treatment relies on chemotherapeutic treatment but, despite an initial response to chemotherapy, the inc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a4842471-6075-5dae-8d9b-9e73ee4b6d9c
DOI: 10.20944/preprints202104.0724.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Enhanced Anticancer Activity of Nanoformulation of Dasatinib against Triple-Negative Breast Cancer by Reduced Metabolic DegradationDOI 10.20944/preprints202104.0724.v1Read

Recent progress in drug delivery systems for tyrosine kinase inhibitors in the treatment of lung cancer.Semantic proximity Read

Enhancing Breast Cancer Therapy: Nanocarrier-Based Targeted Drug DeliverySemantic proximity Read

Multi-mechanistic mitochondria-mediated N-methylated YKWYYRGAA-decorated nano-chitosan conjugate carrier for treatment of NRAS-mutant-harbouring lung carcinoma.Semantic proximity Read

Exploring the synergistic behaviour of paclitaxel and vorinostat upon co-loading in albumin nanoparticles for breast cancer managementSemantic proximity Read

Nanoparticle-based drug delivery systems: What can they really do in vivo?Semantic proximity Read

Nanoparticulate drug combination inhibits DNA damage repair and PD-L1 expression in BRCA-mutant and wild type triple-negative breast cancer.Semantic proximity Read

Engineered MoS₂ Nanoplatforms for Drug-Enhanced Cancer Phototherapy: From Design Strategies to Translational OpportunitiesSemantic proximity Read

Ligand conjugated lipid-based nanocarriers for cancer theranosticsSemantic proximity Read

Red Blood Cell-derived Extracellular Vesicles enable Cisplatin and Cetuximab combined Therapy against Triple-Negative Breast CancerSemantic proximity Read

ADT-OH exhibits anti-metastatic activity on triple-negative breast cancer by combinatorial targeting of autophagy and mitochondrial fissionSemantic proximity Read

Amino Acid Polymer-Based Nano-Carriers for Targeted Drug Delivery in Breast Cancer Therapy: Mechanisms, Applications, and Future PerspectivesSemantic proximity Read

Genetically Engineered Cell Membrane-Coated Nanodrug for Targeted Treatment of Thyroid CancerSemantic proximity Read